Anthrax vaccine market projected to reach USD 2.8 billion by 2031...

0 Comments

Autres

Anthrax vaccine market projected to reach USD 2.8 billion by 2031 as next-generation formulations transform biodefense.

2025-04-19 12:55:12 • Views

[Hyderabad, April 19th, 2025] – The Anthrax Vaccine Market, valued at USD 1.2 billion in 2023, is expected to grow at a rate of 11.3%, reaching USD 2.8 billion by 2031, driven by military needs and breakthrough adjuvants, reports ClearView Market Insights.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-anthrax-vaccine-market/

2024 Key Advances

Improved Immunogenicity

AV7909 achieves 98% seroconversion compared to 83% of legacy vaccines.
Oral and nasal vaccines enter clinical trials, eliminating the need for needles.

Logistics Revolution

Thermostable formulations withstand 25°C for 5 years.
mRNA platform cuts manufacturing time from 12 months to 4.

Dual-Use Potential

TerraCoV2-AM targets both anthrax and coronavirus spikes.
Livestock applications prevent zoonotic transmission.

Regional Preparedness

North America (65%): The US maintains a 50 Mn dose stockpile.
Europe (XX%): NATO countries are standardizing vaccination protocols.
Asia (XX%): China mandates 100 million livestock doses per year.

Executive Insights
"We're moving from 1950s-era vaccines to 21st century molecular designs."
– Robert Kramer, CEO, Emergent BioSolutions

Roadmap to 2031

2025: Next-gen vaccines to comprise 30% of government purchases.
2027: Needle-free options approved for civilian use.
2030: AI-designed antigens may enter clinical testing.

For more insights, visit https://clearviewmarketinsights.com/report-store

About ClearView Market Insights
ClearView Market Insights track 80+ biodefense markets, from vaccines to detection systems.

Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

#Anthrax_vaccine_market

Please log in to like, share and comment!

Anthrax vaccine market projected to reach USD 2.8 billion by 2031 as next-generation formulations transform biodefense.

"Charting the Course: Service Robotics Market Outlook (2023-2029)"

Exploring the Untapped Markets in the Global Endpoint Detection and Response (EDR) Industry

Join

Language

Anthrax vaccine market projected to reach USD 2.8 billion by 2031 as next-generation formulations transform biodefense.

"Charting the Course: Service Robotics Market Outlook (2023-2029)"

Exploring the Untapped Markets in the Global Endpoint Detection and Response (EDR) Industry